ABUS
Price
$3.84
Change
-$0.01 (-0.26%)
Updated
Oct 4 closing price
32 days until earnings call
ROIV
Price
$11.38
Change
+$0.17 (+1.52%)
Updated
Oct 4 closing price
37 days until earnings call
Ad is loading...

ABUS vs ROIV

Header iconABUS vs ROIV Comparison
Open Charts ABUS vs ROIVBanner chart's image
Arbutus Biopharma
Price$3.84
Change-$0.01 (-0.26%)
Volume$636.89K
CapitalizationN/A
Roivant Sciences
Price$11.38
Change+$0.17 (+1.52%)
Volume$4.86M
CapitalizationN/A
View a ticker or compare two or three
ABUS vs ROIV Comparison Chart
Loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABUS vs. ROIV commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a StrongSell and ROIV is a StrongSell.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (ABUS: $3.84 vs. ROIV: $11.38)
Brand notoriety: ABUS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABUS: 52% vs. ROIV: 73%
Market capitalization -- ABUS: $723.04M vs. ROIV: $8.49B
ABUS [@Biotechnology] is valued at $723.04M. ROIV’s [@Biotechnology] market capitalization is $8.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • ABUS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than ABUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 3 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • ABUS’s TA Score: 3 bullish, 7 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than ABUS.

Price Growth

ABUS (@Biotechnology) experienced а +0.26% price change this week, while ROIV (@Biotechnology) price change was -0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

ABUS is expected to report earnings on Nov 06, 2024.

ROIV is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.49B) has a higher market cap than ABUS($723M). ABUS YTD gains are higher at: 53.600 vs. ROIV (1.336). ROIV has higher annual earnings (EBITDA): 4.71B vs. ABUS (-75.48M). ROIV has more cash in the bank: 5.68B vs. ABUS (142M). ABUS has less debt than ROIV: ABUS (1.6M) vs ROIV (379M). ROIV has higher revenues than ABUS: ROIV (158M) vs ABUS (10.1M).
ABUSROIVABUS / ROIV
Capitalization723M8.49B9%
EBITDA-75.48M4.71B-2%
Gain YTD53.6001.3364,013%
P/E RatioN/A2.01-
Revenue10.1M158M6%
Total Cash142M5.68B3%
Total Debt1.6M379M0%
FUNDAMENTALS RATINGS
ABUS: Fundamental Ratings
ABUS
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABUSROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
54%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 19 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBVSX87.180.96
+1.11%
Undiscovered Managers Behavioral Val I
IIVAX29.600.27
+0.92%
Transamerica Small/Mid Cap Value A
LAVRX15.580.14
+0.91%
Lord Abbett Fundamental Equity R3
BISLX11.27-0.01
-0.09%
Brown Advisory Sustainable Intl Ldrs Inv
FHETX18.34-0.06
-0.33%
Fidelity Advisor Real Estate M

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.52%
IMVT - ROIV
61%
Loosely correlated
+4.20%
RVMD - ROIV
48%
Loosely correlated
+2.58%
FOLD - ROIV
47%
Loosely correlated
+0.38%
CRNX - ROIV
44%
Loosely correlated
+0.70%
ABUS - ROIV
44%
Loosely correlated
-0.26%
More